Optum notable drugs nearing FDA approval include Anaphylm, Sotyktu, and insulin icodec with decisions expected early 2026.

Optum Ventures backs oncology AI startup Risa Labs in an $11.1M series A to accelerate AI platform deployment in U.S. cancer care settings.

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $260.0 to $450.0 for UnitedHealth Group over the last 3 months.

The controversial healthcare conglomerate is accused of systematically diagnosing patients with as many conditions as ...

AI startup RISA Labs raises $11.1M Series A to scale its AI operating system for oncology, cutting authorization delays, ...

Gilead Sciences' new HIV prevention drug has been added to CVS Health's commercial insurance plans, the drugmaker's CEO ...

Small told the Port Angeles Business Association on Tuesday at Joshua’s Restaurant that core challenges facing the emergency ...

A new AI tool is being tested in Oklahoma to process prior authorizations in Medicare. These Oklahomans say they're worried.

UnitedHealth faced a series of headwinds in 2025, resulting in a 34% decline in its stock price. The health insurance giant ...

Pharmacy deserts are spreading across America. In one rural Arizona town, the only independent pharmacy is doing everything ...

EVERETT— Local and federal changes to health insurance that went into effect at the start of 2026 have the potential to impact many Snohomish County residents. Also on Jan. 1, enhanced premium tax ...

The Wasteful and Inappropriate Service Reduction Model, or WISeR, is being tested in six states, including Oklahoma, starting ...